A detailed history of Kelly Lawrence W & Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 67,447 shares of MRK stock, worth $6.75 Million. This represents 1.78% of its overall portfolio holdings.

Number of Shares
67,447
Previous 66,823 0.93%
Holding current value
$6.75 Million
Previous $8.27 Million 7.41%
% of portfolio
1.78%
Previous 1.93%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $69,357 - $80,477
624 Added 0.93%
67,447 $7.66 Million
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $118,229 - $126,976
-955 Reduced 1.41%
66,823 $8.27 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $297,821 - $347,028
-2,630 Reduced 3.74%
67,778 $8.94 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $48,086 - $52,329
480 Added 0.69%
70,408 $7.68 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $59,196 - $65,739
-575 Reduced 0.82%
69,928 $7.2 Million
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $341,035 - $371,713
-3,140 Reduced 4.26%
70,503 $8.14 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $194,556 - $217,085
-1,890 Reduced 2.5%
73,643 $7.83 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $2.61 Million - $3.34 Million
-29,800 Reduced 28.29%
75,533 $8.38 Million
Q3 2022

Nov 15, 2022

SELL
$84.53 - $94.96 $39,306 - $44,156
-465 Reduced 0.44%
105,333 $9.07 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $2,087 - $2,366
25 Added 0.02%
105,798 $9.65 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $156,576 - $175,512
2,130 Added 2.06%
105,773 $8.68 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $312,972 - $392,038
-4,330 Reduced 4.01%
103,643 $7.94 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $2,150 - $2,364
30 Added 0.03%
107,973 $8.11 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $103,355 - $114,321
1,470 Added 1.38%
107,943 $8.4 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $2.09 Million - $2.47 Million
30,405 Added 39.97%
106,473 $8.21 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $2.01 Million - $2.23 Million
-28,020 Reduced 26.92%
76,068 $6.22 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $5.01 Million - $5.67 Million
-68,395 Reduced 39.65%
104,088 $8.63 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $4.69 Million - $5.33 Million
66,575 Added 62.86%
172,483 $13.3 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $1.37 Million - $1.9 Million
-21,685 Reduced 17.0%
105,908 $8.15 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $141,583 - $159,760
-1,825 Reduced 1.41%
127,593 $11.6 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $190,200 - $207,325
-2,500 Reduced 1.9%
129,418 $10.9 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $15,015 - $17,541
215 Added 0.16%
131,918 $11.1 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $111,328 - $126,976
-1,600 Reduced 1.2%
131,703 $11 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $372,324 - $432,076
-5,707 Reduced 4.11%
133,303 $10.2 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $40,383 - $47,488
700 Added 0.51%
139,010 $9.86 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $114,367 - $134,370
2,250 Added 1.65%
138,310 $8.4 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $17,836 - $20,730
350 Added 0.26%
136,060 $7.41 Million
Q4 2017

Feb 14, 2018

SELL
$51.62 - $61.64 $4.39 Million - $5.24 Million
-85,011 Reduced 38.52%
135,710 $7.64 Million
Q3 2017

Nov 15, 2017

BUY
$58.67 - $63.13 $12.9 Million - $13.9 Million
220,721
220,721 $14.1 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Kelly Lawrence W & Associates Inc Portfolio

Follow Kelly Lawrence W & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.